A research team has achieved a significant breakthrough in developing broadly protective, live-attenuated influenza vaccines (LAIV). These innovative LAIV platforms offer potential to develop ...

Children with asthma and recurrent wheezing who received the intranasal live attenuated influenza vaccine (LAIV) did not experience increased lower respiratory events (LREs) compared with children who ...

The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) voted 12 to 2 Wednesday to recommend returning the nasal live attenuated influenza ...

Background. Tonsils play a key role in eliciting immune responses against respiratory pathogens. Little is known about how tonsils contribute to the local immune response after intranasal vaccination.

Please provide your email address to receive an email when new articles are posted on . After recommending against the live-attenuated influenza vaccine, or LAIV, for 2 years in a row, the CDC’s ...

A study among U.S. military personnel finds that those who received a flu shot with the trivalent inactivated vaccine had fewer subsequent health care visits related to pneumonia and influenza than ...

PITTSBURGH, April 24, 2017 - Recent federal recommendations against offering the inhaled nasal influenza vaccine due to lack of effectiveness could lead to more flu illness in the U.S. if the inhaled ...

ATLANTA -- After a 2-year absence, FluMist is back on the 2018-2019 influenza vaccine schedule, following a vote from the CDC Advisory Committee on Immunization Practices (ACIP) here. The panel also ...

Influenza row modified to reflect current recommendations for live attenuated flu vaccine. The Advisory Committee on Immunization Practices (ACIP) has voted in favor of a renewed recommendation for ...

BioDiem Ltd. (BDM.AX) Licenses LAIV Technology to Changchun BCHT Biotechnology Co. Melbourne, 9 February 2012: Australian vaccine development company BioDiem Ltd (ASX: BDM) today announced that it has ...

A research team led by the School of Public Health in the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in collaboration with the Center for Immunology & Infection (C2i), has achieved ...